Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
PaperCitations, authors & open-access status
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 279 citations, 2022 year and hybrid oa status.
279
Citations
2022
Year
hybrid
OA Status